CH Biomedical
PrivateLast Round
Series E
Jun 1, 2025
Est. Valuation
$588.2M
Total Funding Raised
$78.8M
Company Overview
CH Biomedical is a medical technology company that develops and manufactures advanced ventricular assist devices (VADs) for the treatment of end-stage heart failure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CH Biomedical Comparables
Compare CH Biomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shenzhen Core Medical Technology Co., Ltd. | 93% | |
| Aerospace Taixin Technology Co., Ltd. | 91% | |
| CorWave | 84% |
CH Biomedical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Jun 1, 2025 | ||||
| Series D | Aug 13, 2021 | ||||
| Series C | Dec 1, 2020 | ||||
| Series B | Apr 1, 2020 | ||||
| Series A | Jun 18, 2019 |
CH Biomedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lake Bleu Capital | Series D |
| Hosen Capital | Series B |
| Neovision Capital | Series E |
| Volcanics Venture | Series C |
| Lingdao Capital | Series D |
| HongShan Capital Group (HSG) | Series E, Series D |
| Gaorong Capital | Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
$64M round with Gaorong Capital, HongShan Capital Group, and Neovision Capital.
- Aug 13, 2021
Led by HongShan Capital Group with participation from Lake Bleu Capital.
CH Biomedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CH Biomedical's valuation, stock price, and market status.
Is CH Biomedical a public or private company?
CH Biomedical is a private company.
What is the current stock price of CH Biomedical?
CH Biomedical is a private company with no public stock price. Caplight tracks CH Biomedical's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is CH Biomedical worth (valuation)?
CH Biomedical's valuation is estimated at $588.2M based on funding round data.
Can I buy CH Biomedical stock?
CH Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CH Biomedical's last funding round?
CH Biomedical's most recent funding round was Series E on June 1, 2025.
Who are the main investors in CH Biomedical?
Key investors in CH Biomedical include HongShan Capital Group (HSG).
Will CH Biomedical IPO soon?
No public IPO plans have been announced for CH Biomedical.
How can I track CH Biomedical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CH Biomedical's secondary market activity and sign up for updates.